Citations

Clear

11 citation(s) found for "Anderson, Bradley".

Association between allelic variants in the glucagon‐like peptide 1 and cholecystokinin receptor genes with gastric emptying and glucose tolerance
Anderson, Bradley J. , Carlson, Paula, LAURENTI, MARCELLO C. , Camilleri, Michael , Desai, Anshuman, Feuerhak, Kelly, Bharucha, Adil E. , Anderson, Bradley, Laurenti, Marcello, Camilleri, M , Bharucha, A E , Vella, Adrian

Mayo Clinic

Neurogastroenterology & Motility | November 6, 2019 | Volume: 32 | Issue: 1 | Pages: No page available

10.1111/nmo.13724 | PMID 31691451 Get It

AbstractBackgroundNutrient‐mediated release of cholecystokinin and glucagon‐like peptide‐1 (GLP‐1) regulates gastric emptying (GE) via duodenogastric feedback mechanisms; GLP‐1 also regulates postprandial insulin secretion. Some patients with functional upper gastrointestinal symptoms have impaired glucose tolerance during enteral dextrose infusion. Our hypothesis was that variants in CCK, GLP‐1, and TCF7L2 (transcription factor 7‐like 2 locus), which is associated with greatest genetic risk for development of type 2 diabetes mellitus, are associated with GE and independently with glucose tolerance. Our aims were to evaluate the associations between these GE, glucose tolerance, and these single nucleotide polymorphisms (SNPs).MethodsGenetic variants, scintigraphic GE of solids, plasma glucose, insulin, and GLP‐1 during enteral dextrose infusion (75gm over 2 hours) were measured. GE and enteral dextrose infusion were, respectively, evaluated in 44 (27 controls and 17 patients with functional dyspepsia or nausea) and 42 (28 controls, 14 patients) participants; of these, 51 participants consented to assessment of SNPs. Four functional SNPs were studied: rs6923761 and rs1042044 at GLP‐1 receptor, rs7903146 (TCF7L2), and rs1800857 (CCK receptor).Key ResultsGastric emptying was normal in 38, rapid in 4, and delayed in two participants; 38 had normal, and four had impaired glucose tolerance. The T allele at rs7903146 (TCF7L2) was non‐significantly associated (P = .14) with faster GE. The associations between SNPs and demographic variables, GE thalf, glucose tolerance and plasma GLP1 levels were not significant.Conclusions & InferencesThere is a trend toward an association between faster GE and the diabetes‐associated allele at rs7903146 in TCF7L2. However, these SNPs were not associated with plasma glucose or GLP1 concentrations during enteral dextrose infusion.
871 Impact of Patient Screening Process on Diagnostic and Therapeutic Yield of Double Balloon Enteroscopy
Liu, Mengfei , Anderson, Bradley J. , Garg, Sushil Kumar , Kane, Sunanda V. , Wang, Xiao‐Jing , Chakraborty, Subhankar , Sánchez, William

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S505-S505

10.14309/01.ajg.0000593020.34408.8f Get It

INTRODUCTION: Double balloon enteroscopy (DBE) is an important tool for evaluation of obscure GI bleeding but is a limited resource given time and expertise required. Patient selection is important to help optimize diagnostic yield and subsequent successful management of small bowel bleeding. To maximize the efficiency of DBE performed, our endoscopy group established a screening protocol (Figure) prior to approval of any procedure. We developed a quality improvement project to assess the efficacy of this screening protocol and to evaluate which components of screening were most predictive for procedural success. METHODS: A retrospective chart review was performed on all patients who underwent anterograde or retrograde double balloon enteroscopy for suspected GI bleeding from January 2016 to December 2017. Our screening protocol was implemented on February 1 st , 2017. Data was obtained on patient demographics, clinical presentation, laboratory evaluation, and prior investigation for bleeding evaluation. Endoscopy outcomes were separated into procedural success, defined as lesion identified, and clinical success, defined as resolution of bleeding. Success rates were compared pre and post intervention. Regression analysis was performed to evaluate which components best predicted a successful procedure. RESULTS: We reviewed 114 DBE procedures in 89 patients, 53.5% male (n = 61) with a mean age of 62.8 + 13.3 years. Of these, 86% (n = 98) were performed prior to initiation of the screening protocol. Overall, there was no significant difference in procedural success pre and post intervention as defined by presence of recurrent bleeding, persistent anemia, or transfusion need (Table 1). On univariate analysis of clinical success, defined as lack of recurrent bleeding, gender, anticoagulation use, and presence of lesion on CE were significant (Table 2). Identification and intervention on a lesion during the balloon endoscopy did not impact future anemia, bleeding, or transfusion requirements. CONCLUSION: The patient screening protocol was successful in decreasing the number of procedures performed but did not improve our lesion detection rate on endoscopy and did not improve clinical outcomes as measured by rebleeding. Patients on anticoagulation and those who had prior lesions identified on capsule endoscopy had higher odds of rebleeding, indicating clinical failure. This data may help modify patient selection to maximize success of DBE procedures in the future.
Idiopathic myointimal hyperplasia is a distinct cause of chronic colon ischaemia
Anderson, Bradley J. , Smyrk, Thomas C. , Graham, Rondell P. , Sweetser, Seth , Graham, Rondell P , Anderson, B., Lightner, Amy L.

Mayo Clinic

Colorectal Disease | May 10, 2019 | Volume: 21 | Issue: 9 | Pages: 1073-1078

10.1111/codi.14685 | PMID 31074117 Get It

AbstractAimColon ischaemia (CI) is most commonly an acute and reversible manifestation of a transient, non‐occlusive decrease of blood flow in the colonic microvasculature. Irreversible complications are uncommon and the progression to chronic CI remains controversial. Our objective was to identify cases of chronic CI and assess for distinct clinicopathological features.MethodA retrospective review was performed of CI patients having symptom chronicity of ≥ 1 month and ischaemic histology at our institution from 1994 to 2015. Demographic, clinical, endoscopic, radiological, pathological and outcome variables were abstracted. Histological evaluation was performed by two gastrointestinal pathologists.ResultsFifteen patients (n = 9; 67% men) with a median age of 65 years (range 22–88) were identified. The most common presenting symptoms were diarrhoea and abdominal pain (n = 6, 86%; n = 5, 71%, respectively). The typical endoscopic appearance was segmental ulceration of the sigmoid colon (n = 6, 75%). Vascular imaging showed patent mesenteric vessels in all patients. Histopathological evaluation revealed venous intimal hyperplasia consistent with idiopathic myointimal hyperplasia of the mesenteric veins (IMHMV) in eight patients; the remainder showed non‐specific ulceration and fibrosis. Surgical resection was performed in seven IMHMV patients, resulting in symptom resolution. On re‐review of pre‐resection biopsies, all IMHMV patients had characteristic changes of hyperplastic, thick‐walled, hyalinized vessels in the lamina propria.ConclusionsIMHMV is a unique histopathological entity causing chronic CI. The small vessel histological changes in IMHMV are distinctive in colonic resections and undetectable by routine vascular imaging. Preoperative diagnosis of IMHMV is possible with endoscopic biopsy and segmental colon resection is curative.
More movement with evaluating colonic transit in humans
Bharucha, Adil E. , Anderson, Bradley J. , Bouchoucha, Michel , Anderson, Bradley

Mayo Clinic

Neurogastroenterology & Motility | January 25, 2019 | Volume: 31 | Issue: 2 | Pages: No page available

10.1111/nmo.13541 | PMID 30681255 Get It

AbstractBackgroundColonic functions (ie, absorption of fluids and electrolytes, digestion of selected nutrients, harbor for microbes, and elimination of excreta) necessitate complex patterns of storage and transit. Indeed, colonic transit accounts for a major part of the mouth‐to‐anus transit time. Colonic transit assessments are useful for understanding the pathophysiology of disease, the pharmacodynamic effects of new medications and to diagnose slow transit constipation. Currently, radiopaque markers, scintigraphy, and a colonic pH‐pressure capsule are used to measure overall colonic transit. Radioopaque markers, scintigraphy, and the electromagnetic capsule, which is a newer technique, also evaluate regional colonic transit. The pH‐pressure capsule also measures colonic pressures. Magnetic resonance imaging and a radio‐frequency identification‐based device are evolving methods for assessing colonic transit.PurposeThis mini‐review, which accompanies a study evaluating the assessment of colon transit with the electromagnetic capsule, evaluates and compares existing and evolving methods for evaluating colonic transit in humans (Neurogastroenterol Motil. 2018; in press). In addition to overall and regional colonic transit, the electromagnetic capsule evaluates colonic motor patterns without radiation exposure. These patterns are summarized by analyzing the characteristics (ie, distance and velocity) of discrete antegrade and retrograde capsule movements as they travel in the colon. However, the electromagnetic capsule does not measure pressure or colonic wall movement (ie, contractions). The motor patterns identified by this capsule should be compared with motor patterns identified with manometry. The next challenge is to harness different techniques to evaluate the relationships between colonic pressures and transit or, even better, the trifecta of colonic contractions, pressure events, and transit.
Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma
Anderson, Bradley W., Suh, Yun‐Suhk , Choi, Boram , Lee, Hyuk‐Joon , Yab, Tracy C. , Dukek, Brian A. , Cao, Xiaoming , Devens, Mary E., Boardman, Lisa A., Slettedahl, Seth W. , Allawi, Hatim T. , Lidgard, Graham P. , Smyrk, Thomas C. , Yang, Han‐Kwang , Ahlquist, David A. , Berger, Calise K. , Foote, Patrick H. , Kisiel, John B. , Mahoney, Douglas W. , Slettedahl, Seth W , Taylor, William R. , Boardman, Lisa A.

Mayo Clinic

Clinical Cancer Research | May 29, 2018 | Volume: 24 | Issue: 22 | Pages: 5724-5734

10.1158/1078-0432.ccr-17-3364 | PMID 29844130 Get It

Abstract Purpose: Gastric adenocarcinoma is the third most common cause of cancer mortality worldwide. Accurate and affordable noninvasive detection methods have potential value for screening and surveillance. Herein, we identify novel methylated DNA markers (MDM) for gastric adenocarcinoma, validate their discrimination for gastric adenocarcinoma in tissues from geographically separate cohorts, explore marker acquisition through the oncogenic cascade, and describe distributions of candidate MDMs in plasma from gastric adenocarcinoma cases and normal controls. Experimental Design: Following discovery by unbiased whole-methylome sequencing, candidate MDMs were validated by blinded methylation-specific PCR in archival case–control tissues from U.S. and South Korean patients. Top MDMs were then assayed by an analytically sensitive method (quantitative real-time allele-specific target and signal amplification) in a blinded pilot study on archival plasma from gastric adenocarcinoma cases and normal controls. Results: Whole-methylome discovery yielded novel and highly discriminant candidate MDMs. In tissue, a panel of candidate MDMs detected gastric adenocarcinoma in 92% to 100% of U.S. and South Korean cohorts at 100% specificity. Levels of most MDMs increased progressively from normal mucosa through metaplasia, adenoma, and gastric adenocarcinoma with variation in points of greatest marker acquisition. In plasma, a 3-marker panel (ELMO1, ZNF569, C13orf18) detected 86% (95% CI, 71–95) of gastric adenocarcinomas at 95% specificity. Conclusions: Novel MDMs appear to accurately discriminate gastric adenocarcinoma from normal controls in both tissue and plasma. The point of aberrant methylation during oncogenesis varies by MDM, which may have relevance to marker selection in clinical applications. Further exploration of these MDMs for gastric adenocarcinoma screening and surveillance is warranted. Clin Cancer Res; 24(22); 5724–34. ©2018 AACR.
Young woman with segmental colitis
Anderson, Bradley W., Sweetser, Seth , Imam, Zaid

Mayo Clinic

Gut | September 12, 2017 | Volume: 67 | Issue: 8 | Pages: 1399-1474

10.1136/gutjnl-2017-315122 | PMID 28899985 Get It

Gastrointestinal: Zollinger–Ellison Syndrome: A rare cause of chronic diarrhea and abdominal pain
Anderson, Bradley J. , Sweetser, Seth

Mayo Clinic

Journal of Gastroenterology and Hepatology | June 23, 2017 | Volume: 32 | Issue: 7 | Pages: 1281-1281

10.1111/jgh.13630 | PMID 28639271 Get It

Relationship of initial quality-of-life deficit and survival in esophageal cancer (EC): The Mayo Clinic Romero Registry experience.
Anderson, Bradley W., Liu, Heshan , Ginos, Brenda, Romero, Yvonne , Jatoi, Aminah , Deschamps, Claude, Sloan, Jeff A. , Sio, Terence T. , Miller, Robert C.

Mayo Clinic

Journal of Clinical Oncology | February 24, 2017 | Volume: 32 | Issue: 3_suppl | Pages: 97-97

10.1200/jco.2014.32.3_suppl.97 Get It

97 Background: A diagnosis of EC significantly impairs patient (pt)’s survival and quality of life (QoL). We explored the relationship between pt-assessed QoL and survival. Methods: The Mayo Clinic Romero (formerly Esophageal Adenocarcinoma-Barrett's Esophagus) Registry prospectively collects clinical data during a pt's treatment course. QoL is recorded at enrollment (baseline) and annually using a validated 12-item Linear Analog Self-Assessment (LASA). A 10-pt scale is applied; ≤5 was termed clinically deficient QoL. Initial TNM staging, clinical (age, sex, prior chemotherapy, and esophagectomy), and socioeconomic variables (marital/employment status) were analyzed using Cox proportional hazards regression models. Results: 836 pts were analyzed. Median age was 64 years. 166, 506 and 164 pts had early, locally advanced, and metastatic EC, with 5-year survival rates of 75.1%, 33.6%, and 8.1%, respectively (P≤.0001). Poorer survival rates were seen in clinically QoL deficient pts in the following categories: Overall QoL (Hazard Ratio [H.R.] 0.66; 95% C.I., 0.54-0.80; P≤.0001) and LASA subsets for physical (H.R. 0.68; 95% C.I., 0.57-0.82; P≤.0001), emotional well-being (H.R. 0.69; C.I., 0.57-0.84; P=.0003), and social activity (H.R. 0.76; C.I., 0.63-0.91; P=.0028). No difference in survival was observed for marital or employment status, familial support, and financial/legal concerns. Pts with esophagectomy prior to LASA evaluation had improved survival (H.R. 0.68; 95% C.I., 0.55-0.85; P=.0005). No survival difference was observed whether pts received chemotherapy, before or after their baseline LASA evaluation. Conclusions: A strong association exists between pt’s overall survival and better overall QOL, physical, emotional well-being, and social activities. Using LASA to clinically monitor QoL at specified intervals may afford providers the opportunity to intervene when patients begin to experience QoL decline. The determinants of clinically deficit QoL and its impact on survival warrant further translational and prospective research.
A case of heart failure and diarrhoea
Anderson, Bradley J. , Rizvi, Sumera, Lin, Grace , Nehra, Vandana, Anderson, Bradley

Mayo Clinic

Gut | November 14, 2016 | Volume: 66 | Issue: 10 | Pages: 1778-1778

10.1136/gutjnl-2016-313077 | PMID 28878045 Get It

Ureteral Cannulation as a Complication of Urethral Catheterization
Anderson, Bradley W., Greenlund, Andrew C.

Mayo Clinic

Korean Journal of Urology | November 12, 2014 | Volume: 55 | Issue: 11 | Pages: 768

10.4111/kju.2014.55.11.768 | PMID 25405021 Get It